OmniAb (OABI) Interest & Investment Income (2022 - 2026)
OmniAb's (OABI) quarterly Interest & Investment Income came in at $487000.0 in Q1 2026, down 9.31% year-on-year from $537000.0 in Q1 2025, and down 60.24% on a QoQ basis from $1.2 million in Q4 2025.
OmniAb (OABI) Interest & Investment Income (2022 - 2026) Analysis & Trends
OmniAb (OABI) has 5 years of Interest & Investment Income data on file, last reported at $487000.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 9.31% year-over-year to $487000.0 in Q1 2026; TTM through Mar 2026 was $2.6 million, a 2.17% decrease from a year earlier, with the FY2025 full-year figure at $2.7 million, down 14.36% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $487000.0, down from $1.2 million in the prior quarter.
- Over the last five years, Interest & Investment Income for OABI reached as high as $1.3 million in Q1 2023 and fell as low as $436000.0 in Q2 2025.
- Historically, Interest & Investment Income has averaged $849642.9 across 5 years, with a median of $738000.0 in 2024.
- Across the five-year window, Interest & Investment Income surged 101.19% in 2023 and plunged 45.38% in 2024, its largest moves.
- Year by year, Interest & Investment Income stood at $587000.0 in 2022, then jumped by 101.19% to $1.2 million in 2023, then tumbled by 44.54% to $655000.0 in 2024, then surged by 87.02% to $1.2 million in 2025, then plunged by 60.24% to $487000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $487000.0 in Q1 2026, $1.2 million in Q4 2025, and $462000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | OmniAb | 260.98 Mn | 211.91 Mn | 14.41 Mn | 487,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 487,000.00 |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 462,000.00 |
| Jun 30, 2025 | 436,000.00 |
| Mar 31, 2025 | 537,000.00 |
| Dec 31, 2024 | 655,000.00 |
| Sep 30, 2024 | 691,000.00 |
| Jun 30, 2024 | 785,000.00 |
| Mar 31, 2024 | 975,000.00 |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | 1.29 Mn |
| Mar 31, 2023 | 1.32 Mn |
| Dec 31, 2022 | 587,000.00 |